Lupin

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE326A01037
  • NSEID: LUPIN
  • BSEID: 500257
INR
1,960.00
18 (0.93%)
BSENSE

Oct 09

BSE+NSE Vol: 3.89 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 641789,
    "name": "Lupin",
    "stock_name": "Lupin",
    "full_name": "Lupin Ltd.",
    "name_url": "stocks-analysis/lupin",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,960.00",
    "chg": 18,
    "chgp": "0.93%",
    "dir": 1,
    "prev_price": "1,942.00",
    "mcapval": "89,268.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 500257,
    "symbol": "LUPIN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE326A01037",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "3.89 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/lupin-641789-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Lupin launches fixed-dose triple combination inhaler for COPD in India",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-10-06 13:25:33",
        "description": "Lupin launches fixed-dose triple combination inhaler for COPD in India  BusinessLine..."
      },
      {
        "title": "Lupin launches fixed-dose triple-combination inhaler for COPD in India",
        "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPMHMycC1EdUZHQzh1Yk9jMzhOU3I4a3FWcFYtSk9rbl9pdTQ1SkpxMGd4NUNBaXZTVV9SUjVENzU5TzB6UlJFODdiUTJWSHNJbGJyekFqVEZOT2M0bFBqaldKWFcwUFh5ZHJncW9wRHY2alhGakJ6a1FzbS0xX3VPRlI5dlN1WmZyZC1PQUdOelYtZUdHaWc2cEdHTjlLVTdQM0pxTjZTVzl6bVE4Zjk3RUx2ZFZUXy1JSGN4V1hGWkNFVDBqYzZ6WE9EOVlabldOekdQTnR30gHbAUFVX3lxTE9nRUNiX29ITDAwY0x3RDJ5dGFNbTVOWU5VaG82em5iSV9yWmxXQVNteGwzZTAwdmc5S3N5OTdKbkZndDlfQjZDRXJ1V3B0V1RRTHE1ZnBXem16VXFhOXo3SWgwNnpoaV94b2xXbDdwbmVCVF9kRlk0STVNNXBBa2l3dTdEMktXTS12VDBrTmtDNUdXcUhzX0hkUjd6dGUzUU5mMkZhOHNkQ3JxWW00Y3FKbTlkZ0R0MFM4b3NZcVhoMDlvTEZKMDA5MXVzYnlLM3FwRU1KU3lwTFhhQQ?oc=5",
        "imagepath": "",
        "date": "2026-10-06 11:20:36",
        "description": "Lupin launches fixed-dose triple-combination inhaler for COPD in India  Business Standard..."
      },
      {
        "title": "Pharma Stocks Gain Momentum: Lupin, Aurobindo Pharma, Medanta & Apollo In Focus",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-10-01 16:31:24",
        "description": "Pharma Stocks Gain Momentum: Lupin, Aurobindo Pharma, Medanta & Apollo In Focus  Business Today..."
      },
      {
        "title": "Lupin receives tentative approval for anticoagulant Apixaban from US FDA",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-28 14:50:49",
        "description": "Lupin receives tentative approval for anticoagulant Apixaban from US FDA  Business Standard..."
      },
      {
        "title": "Lupin receives USFDA tentative approval for Apixaban Oral Suspension 1.25 mg/mL",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-28 09:50:29",
        "description": "Lupin receives USFDA tentative approval for Apixaban Oral Suspension 1.25 mg/mL  Business Standard..."
      },
      {
        "title": "Lupin, Akums, Heritage Foods look relatively strong on charts: Anand James",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-22 07:46:09",
        "description": "Lupin, Akums, Heritage Foods look relatively strong on charts: Anand James  Business Standard..."
      },
      {
        "title": "Dr. Reddys, Lupin shares among buzzing stocks as pharma sector back in focus",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-21 16:54:40",
        "description": "Dr. Reddys, Lupin shares among buzzing stocks as pharma sector back in focus  Business Today..."
      },
      {
        "title": "Lupin, Dabur among oversold stocks; analyst explains terminology, strategy",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-10 11:21:49",
        "description": "Lupin, Dabur among oversold stocks; analyst explains terminology, strategy  Business Standard..."
      }
    ],
    "total": 8,
    "sid": "641789",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/lupin-641789"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "06-Oct-2026",
      "details": "Lupin Launches Formoflo-G MDI Worlds First Fixed-dose Triple Combination Drug for COPD Management.",
      "source": "BSE"
    },
    {
      "caption": "Completion Of Buyback Of Shares By Multicare Pharmaceuticals Philippines Inc.",
      "datetime": "01-Oct-2026",
      "details": "Multicare Pharmaceuticals Philippines Inc. (MPPI) has completed buyback of 30559 shares pursuant to which MPPI has become a step-down wholly owned subsidiary of the Company effective from October 01 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "28-Sep-2026",
      "details": "Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspension.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has declared <strong>900%</strong> dividend, ex-date: 17 Jul 26",
          "dt": "2026-07-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>2:10</strong> stock split, ex-date: 27 Aug 10",
          "dt": "2010-08-27",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 11 Aug 06",
          "dt": "2006-08-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Press Release / Media Release

06-Oct-2026 | Source : BSE

Lupin Launches Formoflo-G MDI Worlds First Fixed-dose Triple Combination Drug for COPD Management.

Completion Of Buyback Of Shares By Multicare Pharmaceuticals Philippines Inc.

01-Oct-2026 | Source : BSE

Multicare Pharmaceuticals Philippines Inc. (MPPI) has completed buyback of 30559 shares pursuant to which MPPI has become a step-down wholly owned subsidiary of the Company effective from October 01 2026.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

28-Sep-2026 | Source : BSE

Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspension.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Lupin Ltd. has declared 900% dividend, ex-date: 17 Jul 26

stock-summary
SPLITS

Lupin Ltd. has announced 2:10 stock split, ex-date: 27 Aug 10

stock-summary
BONUS

Lupin Ltd. has announced 1:1 bonus issue, ex-date: 11 Aug 06

stock-summary
RIGHTS

No Rights history available